
Peter P. De Deyn
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 360 publications
Cognitive correlates of cortical thickness, white matter volume, and resting-state connectivity in mild cognitive impairment.
Journal: Journal of Alzheimer's disease : JAD
Published: January 27, 2026
Limited evidence for heart rate variability as a predictor of cognitive and pathophysiological brain markers.
Journal: Journal of Alzheimer's disease : JAD
Published: December 30, 2025
Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts.
Journal: European journal of neurology
Published: September 25, 2025
Common pathogenic mechanisms in the hippocampus across neurodegenerative dementias: Alzheimer's disease, Down syndrome, and Parkinson's disease.
Journal: NPJ dementia
Published: September 24, 2025
An interpretable machine learning framework with data-informed imaging biomarkers for diagnosis and prediction of Alzheimer's disease.
Journal: Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
Published: September 22, 2025
Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration.
Journal: Nuclear medicine and biology
Published: August 29, 2025
Dementia risk prediction in the general population: external validation of a prediction model in the population-based LifeLines Cohort Study.
Journal: JAR life
Published: July 28, 2025
An Adnp frameshift variant disrupts Wnt signalling inducing chromatocytoskeletal defects and autism-related behaviour in male mice.
Journal: EBioMedicine
Published: July 15, 2025
Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy pathology.
Journal: Neurobiology of aging
Published: June 17, 2025
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.
Journal: The journal of prevention of Alzheimer's disease
Published: May 20, 2025
Systemic inflammation as a central player in the initiation and development of Alzheimer's disease.
Journal: Immunity & ageing : I & A
Published: April 14, 2025
Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system.
Journal: Clinical parkinsonism & related disorders
Published: February 11, 2025
Last Updated: 09/26/2026